Phreesia, Inc. (NYSE:PHR) COO Sells $76,450.53 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,873 shares of Phreesia stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $76,450.53. Following the completion of the transaction, the chief operating officer now owns 779,993 shares in the company, valued at $20,755,613.73. The trade was a 0.37 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Evan Roberts also recently made the following trade(s):

• On Tuesday, October 15th, Evan Roberts sold 1,843 shares of Phreesia stock. The stock was sold at an average price of $21.03, for a total value of $38,758.29.

Phreesia Price Performance

NYSE:PHR traded up $1.44 on Wednesday, reaching $28.42. The stock had a trading volume of 668,317 shares, compared to its average volume of 410,783. The company has a quick ratio of 1.77, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $1.65 billion, a P/E ratio of -19.33 and a beta of 0.94. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $29.16. The stock has a fifty day moving average price of $22.30 and a 200-day moving average price of $22.49.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. During the same period in the prior year, the company earned ($0.58) EPS. Phreesia’s revenue for the quarter was up 16.6% on a year-over-year basis. Research analysts forecast that Phreesia, Inc. will post -1.16 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on PHR shares. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. Truist Financial increased their target price on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Needham & Company LLC restated a “buy” rating and set a $29.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Robert W. Baird decreased their price objective on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a report on Wednesday, December 11th. Finally, Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and upped their target price for the company from $24.00 to $32.00 in a research note on Wednesday. Eleven analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $30.64.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Bank of New York Mellon Corp increased its position in Phreesia by 8.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 214,430 shares of the company’s stock valued at $4,546,000 after acquiring an additional 16,614 shares in the last quarter. Rhumbline Advisers raised its position in Phreesia by 1.0% in the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock worth $1,741,000 after purchasing an additional 853 shares during the last quarter. Hsbc Holdings PLC acquired a new position in Phreesia during the 2nd quarter worth $301,000. Sei Investments Co. boosted its position in Phreesia by 135.3% in the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after buying an additional 95,058 shares during the last quarter. Finally, Ensign Peak Advisors Inc increased its stake in shares of Phreesia by 3.2% in the 2nd quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock valued at $477,000 after buying an additional 700 shares during the period. 92.10% of the stock is owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.